ID

25620

Description

Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00575874

Lien

https://clinicaltrials.gov/show/NCT00575874

Mots-clés

  1. 07/09/2017 07/09/2017 -
Téléchargé le

7 septembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes NCT00575874

Eligibility Type 2 Diabetes NCT00575874

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Description

Diabetes Mellitus, Non-Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
hba1c >6.5% and <10.0%
Description

Glycosylated hemoglobin A

Type de données

boolean

Alias
UMLS CUI [1]
C0019018
fpg >126 mg/dl (7 mmol/l) and < 270 mg/dl (15 mmol/l)
Description

Plasma fasting glucose measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0583513
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of type 1 diabetes
Description

Diabetes Mellitus, Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
history of ketoacidosis
Description

Ketoacidosis

Type de données

boolean

Alias
UMLS CUI [1]
C0220982
current insulin therapy
Description

Insulin regime

Type de données

boolean

Alias
UMLS CUI [1]
C0557978
c-peptide <0.5ng/ml
Description

C-peptide measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202100
imparied hepatic function
Description

Liver Dysfunction

Type de données

boolean

Alias
UMLS CUI [1]
C0086565
nyha class ii-iv cardiac status or hospitalization for chf or ef<40%
Description

Cardiac Status New York Heart Association Classification | Hospitalization Congestive heart failure | Cardiac ejection fraction

Type de données

boolean

Alias
UMLS CUI [1,1]
C1999091
UMLS CUI [1,2]
C1275491
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0018802
UMLS CUI [3]
C0232174
uncontrolled hypertension
Description

Uncontrolled hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C1868885

Similar models

Eligibility Type 2 Diabetes NCT00575874

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c >6.5% and <10.0%
boolean
C0019018 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fpg >126 mg/dl (7 mmol/l) and < 270 mg/dl (15 mmol/l)
boolean
C0583513 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Ketoacidosis
Item
history of ketoacidosis
boolean
C0220982 (UMLS CUI [1])
Insulin regime
Item
current insulin therapy
boolean
C0557978 (UMLS CUI [1])
C-peptide measurement
Item
c-peptide <0.5ng/ml
boolean
C0202100 (UMLS CUI [1])
Liver Dysfunction
Item
imparied hepatic function
boolean
C0086565 (UMLS CUI [1])
Cardiac Status New York Heart Association Classification | Hospitalization Congestive heart failure | Cardiac ejection fraction
Item
nyha class ii-iv cardiac status or hospitalization for chf or ef<40%
boolean
C1999091 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C0019993 (UMLS CUI [2,1])
C0018802 (UMLS CUI [2,2])
C0232174 (UMLS CUI [3])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial